BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36444166)

  • 1. Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure.
    Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Nadwa EH; Albogami SM; Alorabi M; Saad HM; Batiha GE
    J Diabetes; 2022 Dec; 14(12):806-814. PubMed ID: 36444166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GDF15-GFRAL pathway is dispensable for the effects of metformin on energy balance.
    Klein AB; Nicolaisen TS; Johann K; Fritzen AM; Mathiesen CV; Gil C; Pilmark NS; Karstoft K; Blond MB; Quist JS; Seeley RJ; Færch K; Lund J; Kleinert M; Clemmensen C
    Cell Rep; 2022 Aug; 40(8):111258. PubMed ID: 36001956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss.
    Day EA; Ford RJ; Smith BK; Mohammadi-Shemirani P; Morrow MR; Gutgesell RM; Lu R; Raphenya AR; Kabiri M; McArthur AG; McInnes N; Hess S; Paré G; Gerstein HC; Steinberg GR
    Nat Metab; 2019 Dec; 1(12):1202-1208. PubMed ID: 32694673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDF15 mediates the effects of metformin on body weight and energy balance.
    Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
    Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knocking on GDF15's door for the treatment of type 2 diabetes mellitus.
    Aguilar-Recarte D; Barroso E; Palomer X; Wahli W; Vázquez-Carrera M
    Trends Endocrinol Metab; 2022 Nov; 33(11):741-754. PubMed ID: 36151002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
    Mullican SE; Lin-Schmidt X; Chin CN; Chavez JA; Furman JL; Armstrong AA; Beck SC; South VJ; Dinh TQ; Cash-Mason TD; Cavanaugh CR; Nelson S; Huang C; Hunter MJ; Rangwala SM
    Nat Med; 2017 Oct; 23(10):1150-1157. PubMed ID: 28846097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.
    Siddiqui JA; Pothuraju R; Khan P; Sharma G; Muniyan S; Seshacharyulu P; Jain M; Nasser MW; Batra SK
    Cytokine Growth Factor Rev; 2022 Apr; 64():71-83. PubMed ID: 34836750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.
    Wang D; Day EA; Townsend LK; Djordjevic D; Jørgensen SB; Steinberg GR
    Nat Rev Endocrinol; 2021 Oct; 17(10):592-607. PubMed ID: 34381196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
    Emmerson PJ; Wang F; Du Y; Liu Q; Pickard RT; Gonciarz MD; Coskun T; Hamang MJ; Sindelar DK; Ballman KK; Foltz LA; Muppidi A; Alsina-Fernandez J; Barnard GC; Tang JX; Liu X; Mao X; Siegel R; Sloan JH; Mitchell PJ; Zhang BB; Gimeno RE; Shan B; Wu X
    Nat Med; 2017 Oct; 23(10):1215-1219. PubMed ID: 28846098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets.
    Rochette L; Zeller M; Cottin Y; Vergely C
    Trends Endocrinol Metab; 2020 Dec; 31(12):939-951. PubMed ID: 33172749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight.
    Zhang SY; Bruce K; Danaei Z; Li RJW; Barros DR; Kuah R; Lim YM; Mariani LH; Cherney DZ; Chiu JFM; Reich HN; Lam TKT
    Cell Metab; 2023 May; 35(5):875-886.e5. PubMed ID: 37060902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
    Yang L; Chang CC; Sun Z; Madsen D; Zhu H; Padkjær SB; Wu X; Huang T; Hultman K; Paulsen SJ; Wang J; Bugge A; Frantzen JB; Nørgaard P; Jeppesen JF; Yang Z; Secher A; Chen H; Li X; John LM; Shan B; He Z; Gao X; Su J; Hansen KT; Yang W; Jørgensen SB
    Nat Med; 2017 Oct; 23(10):1158-1166. PubMed ID: 28846099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.
    Tsai VWW; Husaini Y; Sainsbury A; Brown DA; Breit SN
    Cell Metab; 2018 Sep; 28(3):353-368. PubMed ID: 30184485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?
    Breit SN; Brown DA; Tsai VW
    Annu Rev Physiol; 2021 Feb; 83():127-151. PubMed ID: 33228454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS.
    Tsai VW; Zhang HP; Manandhar R; Schofield P; Christ D; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Brown DA; Breit SN
    Int J Obes (Lond); 2019 Dec; 43(12):2370-2380. PubMed ID: 31152154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positive feedback loop between AMPK and GDF15 promotes metformin antidiabetic effects.
    Aguilar-Recarte D; Barroso E; Zhang M; Rada P; Pizarro-Delgado J; Peña L; Palomer X; Valverde ÁM; Wahli W; Vázquez-Carrera M
    Pharmacol Res; 2023 Jan; 187():106578. PubMed ID: 36435271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.
    Díaz M; Carreras-Badosa G; Villarroya J; Gavaldà-Navarro A; Bassols J; de Zegher F; López-Bermejo A; Villarroya F; Ibáñez L
    Pediatr Res; 2023 Mar; 93(4):964-968. PubMed ID: 35817957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Obesity and Cachexia: Identification of the GFRAL Receptor-MIC-1/GDF15 Pathway.
    Breit SN; Tsai VW; Brown DA
    Trends Mol Med; 2017 Dec; 23(12):1065-1067. PubMed ID: 29129392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
    Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
    Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDF15 promotes weight loss by enhancing energy expenditure in muscle.
    Wang D; Townsend LK; DesOrmeaux GJ; Frangos SM; Batchuluun B; Dumont L; Kuhre RE; Ahmadi E; Hu S; Rebalka IA; Gautam J; Jabile MJT; Pileggi CA; Rehal S; Desjardins EM; Tsakiridis EE; Lally JSV; Juracic ES; Tupling AR; Gerstein HC; Paré G; Tsakiridis T; Harper ME; Hawke TJ; Speakman JR; Blondin DP; Holloway GP; Jørgensen SB; Steinberg GR
    Nature; 2023 Jul; 619(7968):143-150. PubMed ID: 37380764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.